New Jersey · 2026-2027 Regular Session · Bill

S 4017: Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation.

In committee Last action March 19, 2026: Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Plain-language summary

S 4017 is a bill introduced in the New Jersey Senate on March 19, 2026. According to its official title, it concerns: Requires DOH to purchase xylazine test strips to be distributed to entities that provide authorized harm reduction services; makes appropriation. Primary sponsor: Joe Vitale (Democratic). Most recent recorded action (March 19, 2026): Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee.

Sponsors

Primary sponsor: Joe Vitale (Democratic).